scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1471-4159.2006.04130.X |
P8608 | Fatcat ID | release_673chisrsbc3bj6jd752dkkzti |
P698 | PubMed publication ID | 16942596 |
P5875 | ResearchGate publication ID | 6845400 |
P50 | author | Maria M Malagon | Q72776587 |
Jérôme Leprince | Q38544634 | ||
P2093 | author name string | David Chatenet | |
Hubert Vaudry | |||
Marie-Christine Tonon | |||
Hélène Castel | |||
Isabelle Lihrmann | |||
Pierrick Gandolfo | |||
Christophe Dubessy | |||
Marc Fontaine | |||
Laurence Desrues | |||
Marie-Thérèse Schouft | |||
Mickaël Diallo | |||
Elisabeth Scalbert | |||
P2860 | cites work | Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. | Q41981084 |
The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals | Q42213734 | ||
Behavioral effects of urotensin-II centrally administered in mice | Q42667921 | ||
Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. | Q43264408 | ||
Purification and Characterization of Urotensin II and Parvalbumin from an Elasmobranch Fish, Scyliorhinus canicula (Common Dogfish) | Q43948479 | ||
Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons | Q44208844 | ||
Central cardiovascular action of urotensin II in conscious rats | Q44289130 | ||
Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction | Q44564935 | ||
Central cardiovascular action of urotensin II in spontaneously hypertensive rats | Q44657728 | ||
Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. | Q45100855 | ||
Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord | Q46443019 | ||
Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes | Q46610338 | ||
Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. | Q47928974 | ||
Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents | Q47938344 | ||
Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. | Q48418381 | ||
Localization of the urotensin II receptor in the rat central nervous system | Q48675996 | ||
The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors | Q48762716 | ||
Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. | Q48877778 | ||
Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines. | Q51840588 | ||
Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. | Q54708765 | ||
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 | ||
Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors | Q24322675 | ||
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord | Q24656200 | ||
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 | Q24674639 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction | Q28137875 | ||
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 | Q28139196 | ||
Human urotensin II mediates vasoconstriction via an increase in inositol phosphates | Q28140469 | ||
Central effects of urotensin-II following ICV administration in rats | Q28205107 | ||
Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues | Q28207844 | ||
Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain | Q28208515 | ||
The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat | Q28211211 | ||
Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model | Q28219479 | ||
Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors | Q28238520 | ||
A new paradigm for hormone recognition and allosteric receptor activation revealed from structural studies of NPR-C | Q28252415 | ||
Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System | Q28261953 | ||
Cardiovascular effects of urotensin II in different brain areas | Q28577178 | ||
Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord | Q28579322 | ||
Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). | Q30807054 | ||
Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. | Q33183600 | ||
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease | Q34204725 | ||
Oligomerization of G-protein-coupled transmitter receptors. | Q34205602 | ||
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines | Q35047377 | ||
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors | Q35153734 | ||
Dimerization of G-protein-coupled receptors: roles in signal transduction | Q35592680 | ||
Emerging roles of urotensin-II in cardiovascular disease. | Q35909083 | ||
Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes | Q36404166 | ||
Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides | Q40436635 | ||
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors | Q40549079 | ||
Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey | Q40735770 | ||
Urotensin II evokes potent vasoconstriction in humans in vivo | Q41834073 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | astrocyte | Q502961 |
P304 | page(s) | 582-595 | |
P577 | publication date | 2006-08-29 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes | |
P478 | volume | 99 |
Q37737587 | A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects |
Q42252347 | Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart |
Q64059533 | Cadmium-induced genome-wide DNA methylation changes in growth and oxidative metabolism in Drosophila melanogaster |
Q90598614 | Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours |
Q36781030 | Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation. |
Q34260110 | Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity |
Q34359688 | Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. |
Q30480840 | Microglial cells in astroglial cultures: a cautionary note |
Q45817009 | Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis |
Q48821556 | Prenatal exposure to cigarette smoke enhances oxidative stress in astrocytes of neonatal rat. |
Q46594255 | Protective effect of the octadecaneuropeptide on hydrogen peroxide-induced oxidative stress and cell death in cultured rat astrocytes |
Q48372089 | Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma. |
Q38533390 | State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells |
Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
Q34395516 | The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism. |
Q41635046 | The stimulatory effect of the octadecaneuropeptide ODN on astroglial antioxidant enzyme systems is mediated through a GPCR. |
Q43146165 | The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation |
Q51970096 | Transcriptional profiling of the megabladder mouse: a unique model of bladder dysmorphogenesis. |
Q41767436 | Update on the urotensinergic system: new trends in receptor localization, activation, and drug design |
Q45732640 | Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis |
Search more.